400. Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital

BACKGROUND: Secondary bacterial/fungal infection in patients with pandemic strains of Influenza has been well documented in the literature. Little is known about the development of secondary bacterial or fungal infections in patients with COVID-19. Additionally, COVID patients receiving tocilizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Usiak, Shauna, DiFilippo, Laurie, Frattellone, Meredith, Kincart, Mary, Kerr, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778001/
http://dx.doi.org/10.1093/ofid/ofaa439.595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778001/
http://dx.doi.org/10.1093/ofid/ofaa439.595

Ejemplares similares